Inogen, Inc (INGN) earnings

INGN earnings moved a median of +0.24% by the close. Quarterly and annual INGN reports and results, each read against the price at its own news timestamp. Back to the INGN overview →

30 measured INGN earnings events.

Where these INGN earnings landedvs 29 measured INGN earnings reactions
INGN earningsMiddle 50% · -2.09% to +3.17%Zero: 0.00%Median: +0.24%Median +0.24%-4.00%0+4.00%
Middle 50% of INGN earnings reactions-2.09% to +3.17%
Median reaction (to close)+0.24%
Measured reactions29
Point-in-time · zero look-ahead

Half of the 29 INGN earnings events with a measured close landed between -2.09% and +3.17%; 55% closed up.

DateHeadlineEvent5-minTo close
Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026Press release—+0.24%
Form 10-Q Inogen Inc For: Jun 30SEC filing · Form 10-Q+2.15%—
Inogen Announces Second Quarter 2026 Financial ResultsPress release-0.68%+2.72%
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026Press release+1.41%+3.42%
Form 10-Q Inogen Inc For: Mar 31SEC filing · Form 10-Q-4.89%-4.75%
Inogen Announces First Quarter 2026 Financial ResultsPress release-1.40%-2.09%
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026Press release-1.95%-2.51%
Form 10-K Inogen Inc For: Dec 31SEC filing · Form 10-K+0.33%+3.17%
Form 10-Q Inogen Inc For: Sep 30SEC filing · Form 10-Q-1.70%-1.13%
Inogen Announces Third Quarter 2025 Financial ResultsPress release+0.19%-7.86%
Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025Press release-0.54%+1.43%
Form 10-Q Inogen Inc For: Jun 30SEC filing · Form 10-Q+0.15%+8.31%
Inogen Announces Second Quarter 2025 Financial ResultsPress release+9.86%+8.00%
Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025Press release+0.61%+2.14%
Form 10-Q Inogen Inc For: Mar 31SEC filing · Form 10-Q-1.10%-1.58%
Inogen Announces First Quarter 2025 Financial ResultsPress release+0.28%-12.05%
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025Press release-0.69%-4.44%
Form 10-K Inogen Inc For: Dec 31SEC filing · Form 10-K+2.52%-2.28%
Form 10-Q Inogen Inc For: Sep 30SEC filing · Form 10-Q+1.89%-0.63%
Inogen Announces Third Quarter 2024 Financial ResultsPress release-0.65%+3.16%
Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024Press release-0.85%-1.60%
Form 10-Q Inogen Inc For: Jun 30SEC filing · Form 10-Q-2.64%+2.82%
Inogen Announces Second Quarter 2024 Financial ResultsPress release+4.39%+8.10%
Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024Press release-1.33%+3.61%
Form 10-Q Inogen Inc For: Mar 31SEC filing · Form 10-Q+0.00%+5.98%
Inogen Announces First Quarter 2024 Financial ResultsPress release+1.28%+0.49%
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024Press release+0.81%-0.14%
Form 10-K Inogen Inc For: Dec 31SEC filing · Form 10-K-1.42%-5.11%
Form 10-Q Inogen Inc For: Sep 30SEC filing · Form 10-Q+0.00%+0.21%
Inogen Announces Third Quarter 2023 Financial ResultsPress release-7.26%+5.04%
That’s how INGN usually reacts to earnings — get an email when it moves on news →
Keep exploring

More INGN: analyst actions → · SEC filings → · INGN overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
The Joint Corp. (JYNT)2000.00%45%
ProPhase Labs, Inc. (PRPH)198-0.18%44%
Protalix BioTherapeutics, Inc. (DE) (PLX)1970.00%43%
AC Immune SA (ACIU)195-0.43%42%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.